ABL Texcell Diagnostics SA (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.380
-0.020 (-0.83%)
Nov 11, 2026, 4:47 PM CET
ABL Texcell Diagnostics Market Cap
ABL Texcell Diagnostics has a market cap or net worth of €38.25 million as of November 11, 2026. It is the 31,122nd most valuable company in the world and the 386th biggest in France. Its market cap has decreased by 14.01% in one year.
Market Cap
38.25M
Enterprise Value
39.20M
Revenue
11.13M
Global Rank
Country Rank
#386 France
PE Ratio
19.34
ChartMarket Cap Chart
Since November 17, 2000, ABL Texcell Diagnostics's market cap has increased from 2.51M to 38.25M, an increase of 1,424.87%. That is a compound annual growth rate of 11.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 38.25M | -20.89% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 102.72B |
| EssilorLuxottica Société anonyme | 83.88B |
| Sartorius Stedim Biotech | 21.66B |
| Eurofins Scientific SE | 14.90B |
| THX Pharma Société Anonyme | 49.74M |
| Theraclion | 48.54M |
| AB Science | 46.73M |
| OSE Immunotherapeutics | 41.32M |